Nisa Investment Advisors’s 10x Genomics TXG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$105K Buy
4,940
+2,526
+105% +$50.5K ﹤0.01% 1403
2025
Q4
$39.4K Hold
2,414
﹤0.01% 1698
2025
Q3
$28.2K Buy
2,414
+568
+31% +$7.41K ﹤0.01% 1836
2025
Q2
$21.4K Buy
+1,846
New +$16.8K ﹤0.01% 1906
2025
Q1
Sell
-16,500
Closed -$237K 3061
2024
Q4
$237K Buy
+16,500
New +$260K ﹤0.01% 1246
2024
Q2
Sell
-28,200
Closed -$1.06M 2975
2024
Q1
$1.06M Hold
28,200
0.01% 867
2023
Q4
$1.58M Hold
28,200
0.01% 725
2023
Q3
$1.16M Hold
28,200
0.01% 825
2023
Q2
$1.57M Hold
28,200
0.01% 739
2023
Q1
$1.57M Hold
28,200
0.01% 722
2022
Q4
$1.03M Buy
+28,200
New +$922K 0.01% 905
2022
Q3
Sell
-16,600
Closed -$751K 2638
2022
Q2
$751K Buy
16,600
+12,800
+337% +$664K 0.01% 917
2022
Q1
$289K Buy
+3,800
New +$332K ﹤0.01% 1238
2021
Q4
Sell
-900
Closed -$131 2326
2021
Q3
$131 Sell
900
-22,338
-96% -$3.84M ﹤0.01% 1583
2021
Q2
$4.55K Buy
23,238
+18,600
+401% +$3.37M 0.03% 472
2021
Q1
$839 Hold
4,638
0.01% 1028
2020
Q4
$657K Buy
4,638
+2,655
+134% +$385K ﹤0.01% 1077
2020
Q3
$247K Buy
+1,983
New +$208K ﹤0.01% 1255

Other funds holding TXG

Nisa Investment Advisors's TXG Position: Q1 2026 in Review

Nisa Investment Advisors increased its 10x Genomics (TXG) stake by 105% in Q1 2026, buying an estimated $50.5K and bringing the position to 4,940 shares worth $105K. The position accounts for ﹤0.01% of the portfolio, ranked #1403.

Nisa Investment Advisors first reported a position in TXG in Q3 2020 and has held it in 18 quarters since. The position peaked at $1.58M in Q4 2023. 329 funds tracked by Wall St. Rank hold TXG as of Q1 2026.

  • Nisa Investment Advisors held 4,940 shares of 10x Genomics worth $105K as of Q1 2026.
  • Nisa Investment Advisors bought 2,526 10x Genomics shares in Q1 2026, an estimated $50.5K.
  • 10x Genomics made up ﹤0.01% of Nisa Investment Advisors's portfolio in Q1 2026, its #1403 holding.
  • Nisa Investment Advisors first reported a position in 10x Genomics in Q3 2020 and has held it in 18 quarters since.
  • Nisa Investment Advisors's 10x Genomics position peaked at $1.58M in Q4 2023.
  • 329 funds tracked by Wall St. Rank held 10x Genomics as of Q1 2026.

Based on Nisa Investment Advisors's 13F filing for Q1 2026, filed 30 Apr 2026.